Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclizine vs metoclopramide vs ondansetron combined with dexamethasone for prevention of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy
PACTR202303703098345Phase 0Completed
- Sponsor
- Kasr Al Ainy
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised trial of cyclizine, metoclopramide, ondansetron and dexamethasone in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Kasr Al Ainy. Primary endpoint: Incidence of postoperative nausea and vomiting in first 24 hours. Started Nov 2022; status: completed.
02
Drugs
cyclizinemetoclopramideondansetrondexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on PACTR202303703098345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202303703098345.